Yang Qing-Lin, Xie Yipeng, Qiao Kailiang, Lim Jun Yi Stanley, Wu Sihan
Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Cell Res. 2025 Jan;35(1):11-22. doi: 10.1038/s41422-024-01054-8. Epub 2025 Jan 3.
Genomic instability is a hallmark of cancer and is a major driving force of tumorigenesis. A key manifestation of genomic instability is the formation of extrachromosomal DNAs (ecDNAs) - acentric, circular DNA molecules ranging from 50 kb to 5 Mb in size, distinct from chromosomes. Ontological studies have revealed that ecDNA serves as a carrier of oncogenes, immunoregulatory genes, and enhancers, capable of driving elevated transcription of its cargo genes and cancer heterogeneity, leading to rapid tumor evolution and therapy resistance. Although ecDNA was documented over half a century ago, the past decade has witnessed a surge in breakthrough discoveries about its biological functions. Here, we systematically review the modern biology of ecDNA uncovered over the last ten years, focusing on how discoveries during this pioneering stage have illuminated our understanding of ecDNA-driven transcription, heterogeneity, and cancer progression. Furthermore, we discuss ongoing efforts to target ecDNA as a novel approach to cancer therapy. This burgeoning field is entering a new phase, poised to reshape our knowledge of cancer biology and therapeutic strategies.
基因组不稳定是癌症的一个标志,也是肿瘤发生的主要驱动力。基因组不稳定的一个关键表现是染色体外DNA(ecDNA)的形成——一种无着丝粒的环状DNA分子,大小从50 kb到5 Mb不等,与染色体不同。本体研究表明,ecDNA作为癌基因、免疫调节基因和增强子的载体,能够驱动其携带基因的转录增加和癌症异质性,导致肿瘤快速进化和产生耐药性。尽管ecDNA在半个多世纪前就有记载,但在过去十年中,关于其生物学功能的突破性发现激增。在这里,我们系统地回顾了过去十年中发现的ecDNA的现代生物学,重点关注这一开创性阶段的发现如何阐明了我们对ecDNA驱动的转录、异质性和癌症进展的理解。此外,我们还讨论了将ecDNA作为癌症治疗新方法的正在进行的研究。这个新兴领域正在进入一个新阶段,有望重塑我们对癌症生物学和治疗策略的认识。